Summary

Eligibility
for females (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Miriam Kuppermann, PhD, MPH (ucsf)
Headshot of Miriam Kuppermann
Miriam Kuppermann

Description

Summary

This is a randomized comparative effectiveness study of two forms of enhanced prenatal care among 2,600 Medi-Cal eligible pregnant women in Fresno, California. The goal is to see whether group prenatal care with wrap around services versus individual prenatal care supplemented by services covered by the California Department of Public Health Comprehensive Perinatal Services Program (CPSP) results in lower rates of preterm birth, less depression and anxiety, and more respectful and greater satisfaction with prenatal care.

Official Title

Comparing Approaches to Enhanced Prenatal Care to Improve Maternal and Child Health in Central CA

Keywords

Premature Birth, Pregnancy Preterm, Prenatal Stress, Depression, Anxiety, Depression, Postpartum, Satisfaction, Patient, Health Problems in Pregnancy, Group Prenatal Care, Respectful Care, Patient Satisfaction, Prenatal Depression and Anxiety, Low Income, Health Inequity, Prenatal Care, Postpartum Depression, Depression, Depressive Disorder, Glow! Group Prenatal Care, Individual Prenatal Care with CPSP

Eligibility

You can join if…

Open to females

  • Between 8 and 20 weeks gestation at enrollment
  • Eligible for Medi-Cal (at or below 213% of the federal poverty level)
  • Speak English or Spanish

You CAN'T join if...

  • Unavailable to attend group prenatal care sessions
  • Not planning to continue prenatal care with site provider
  • Cannot legally consent to participate in the study

Location

  • Central Valley Health Policy Institute accepting new patients
    Fresno California 93710 United States

Lead Scientist at University of California Health

  • Miriam Kuppermann, PhD, MPH (ucsf)
    Miriam Kuppermann is a Professor in the Departments of Obstetrics, Gynecology & Reproductive Sciences (primary) and Epidemiology & Biostatistics (secondary).

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT04154423
Study Type
Interventional
Participants
Expecting 2600 study participants
Last Updated